Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10464989 Polypeptides, cells, and methods involving engineered CD16

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
March 27, 2015
Date of Patent
November 5, 2019
Patent Application Number
15300024
Patent Citations Received
‌
US Patent 11883432 Chimeric antigen receptor system with adaptable receptor specificity
0
‌
US Patent 11352607 Genomic engineering of pluripotent cells
‌
US Patent 11365394 Enhanced immune effector cells and use thereof
‌
US Patent 11370825 Polypeptides, cells, and methods involving engineered CD16
‌
US Patent 10858628 Methods and compositions for inducing hematopoietic cell differentiation
‌
US Patent 10947505 Methods and compositions for inducing hematopoietic cell differentiation
‌
US Patent 11072781 Genomic engineering of pluripotent cells
‌
US Patent 11634688 Methods and compositions for inducing hematopoietic cell differentiation
0
‌
US Patent 11661459 Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10464989
Patent Primary Examiner
Quang Nguyen
Quang Nguyen

Find more entities like US Patent 10464989 Polypeptides, cells, and methods involving engineered CD16

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.